chlorpromazine has been researched along with amantadine in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (44.44) | 18.7374 |
1990's | 3 (6.67) | 18.2507 |
2000's | 11 (24.44) | 29.6817 |
2010's | 10 (22.22) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Bednarczyk, D; Ekins, S; Wikel, JH; Wright, SH | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Goldberg, LI | 1 |
Borsy, J; Dunai-Kovács, Z; Székely, JI | 1 |
Pakszys, W | 1 |
Messiha, FS | 3 |
Donath, E; Egger, M; Glaser, R; Ziemer, S | 1 |
Berencsi, K; Földeák, S; Mándi, Y; Molnár, J; Prágai, B | 1 |
Kamianov, IM; Katsen, IZ; Kupisk, AG | 1 |
Schergna, E | 1 |
Lahti, RA; McAllister, B; Wozniak, J | 1 |
Andrews, C; Lance, JW | 1 |
Eigeman, L; Vaatstra, WJ | 1 |
Abuzzahab, FS; Kelly, JT; Schiele, BC; Zimmermann, RL | 1 |
Rivera-Calimlim, L | 1 |
Clark, WG; Fleming, RM; Menon, MK | 1 |
Hackman, R; Neuvonen, PJ; Pentikainen, P; Vapaatalo, H | 1 |
Baran, L; Maj, J; Sarnek, J; Sowińska, H | 1 |
Baran, L; Maj, J; Sowińska, H | 1 |
Craddock, G; Fahn, S; Kumin, G | 1 |
Florio, V | 1 |
Kleinrok, Z; Szurska, G | 1 |
Hostetler, KY; Matsuzawa, Y | 1 |
Cornelissen, E; Dewerchin, HL; Nauwynck, HJ; Van Hamme, E; Verhasselt, B | 1 |
1 review(s) available for chlorpromazine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for chlorpromazine and amantadine
Article | Year |
---|---|
A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Benztropine; Capsules; Chlorpromazine; Clinical Trials as Topic; Humans; Parkinson Disease; Parkinson Disease, Secondary; Placebos; Schizophrenia; Time Factors | 1974 |
43 other study(ies) available for chlorpromazine and amantadine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1.
Topics: Computational Biology; HeLa Cells; Humans; Models, Molecular; Organic Cation Transporter 1; Pyridinium Compounds; Quinolinium Compounds; Structure-Activity Relationship; Transfection | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Comparison of putative dopamine receptors in blood vessels and the central nervous system.
Topics: Amantadine; Amphetamine; Animals; Aporphines; Arteries; Brain; Chlorpromazine; Dogs; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Kidney; Piribedil; Receptors, Drug; Thioridazine; Trifluoperazine; Tyramine | 1975 |
The effect of anti-parkinsonian drugs on chlorpromazine-induced depression of operant behaviour.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Atropine; Behavior, Animal; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Phenothiazines; Rats; Trihexyphenidyl | 1976 |
[Interaction between L-dopa and other drugs].
Topics: Amantadine; Anti-Arrhythmia Agents; Apomorphine; Chlorpromazine; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1976 |
Genotype-treatment interaction between amantadine and chlorpromazine in the mouse.
Topics: Amantadine; Animals; Biogenic Amines; Brain; Chlorpromazine; Dopamine; Drug Interactions; Genotype; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Motor Activity; Normetanephrine; Serotonin; Time Factors | 1991 |
Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain.
Topics: Amantadine; Animals; Basal Ganglia Diseases; Chlorpromazine; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Motor Activity; Rats; Rats, Inbred Strains; Species Specificity | 1991 |
Gonadal alcohol and aldehyde dehydrogenase: in vivo and in vitro effects of psychoactive and endocrine agents.
Topics: Alcohol Dehydrogenase; Aldehyde Dehydrogenase; Amantadine; Animals; Chlorpromazine; Enkephalin, Leucine; Epididymis; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Papaverine; Psychotropic Drugs; Rats; Rats, Inbred Strains; Reserpine; Scopolamine; Species Specificity; Testis | 1990 |
Electrorotation--a new method for investigating membrane events during thrombocyte activation. Influence of drugs and osmotic pressure.
Topics: Adamantane; Amantadine; Blood Platelets; Calcimycin; Cell Membrane; Chlorpromazine; Electrochemistry; Humans; Light; Mathematics; Osmotic Pressure; Platelet Aggregation; Rimantadine; Scattering, Radiation; Thrombin | 1986 |
Comparative study of antiproliferative effects of chlorpromazine, 7,8-dioxochlorpromazine, amantadine-N-mustard, rutin-N-mustard and alpha, beta and gamma interferon on K-562 cells in vitro.
Topics: Amantadine; Antineoplastic Agents, Phytogenic; Cell Division; Cell Line; Chlorpromazine; Cytotoxicity, Immunologic; DNA Replication; Humans; Interferon Type I; Interferon-gamma; Leukemia, Myeloid; Monocytes; Nitrogen Mustard Compounds; Protein Biosynthesis; Rutin; Transcription, Genetic | 1985 |
[Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Catatonia; Chlorpromazine; Facial Muscles; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Muscle Cramp; Neck; Parasympatholytics; Parkinson Disease, Secondary; Pharyngeal Diseases; Respiratory Insufficiency; Schizophrenia; Schizophrenia, Paranoid; Speech Disorders; Tachycardia; Tranquilizing Agents | 1973 |
[Recent therapeutic conquests in extrapyramidal syndromes].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Amantadine; Athetosis; Brain Diseases; Central Nervous System Diseases; Chlorpromazine; Chorea; Creutzfeldt-Jakob Syndrome; Dibenzazepines; Dimercaprol; Humans; Huntington Disease | 1970 |
Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
Topics: Amantadine; Animals; Apomorphine; Brain; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Haloperidol; Homovanillic Acid; Mice; Morphine; Phenylacetates; Receptors, Adrenergic; Structure-Activity Relationship; Synaptic Transmission; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1972 |
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes.
Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Movement Disorders; Peripheral Nervous System Diseases; Sensation; Syndrome; Toes | 1973 |
Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Chlorpromazine; Corpus Striatum; Dopamine; Male; Rats; Time Factors; Tritium; Tyrosine | 1974 |
Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa.
Topics: Amantadine; Animals; Biological Transport; Carbon Isotopes; Chlorpromazine; Dihydroxyphenylalanine; Drug Interactions; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Neomycin; Phenobarbital; Rats | 1972 |
Blockade of the central effects of d-amphetamine sulfate by amantadine hydrochloride.
Topics: Amantadine; Animals; Behavior, Animal; Caudate Nucleus; Chlorpromazine; Dextroamphetamine; Male; Mice; Phenylacetates; Time Factors | 1973 |
Inhibition of the apomorphine gnawing compulsion by amantadine.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Synergism; Male; Metoclopramide; Rats | 1973 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlorpromazine; Dextroamphetamine; Disulfides; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Imidazoles; Male; Methyltyrosines; Motor Activity; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Reflex; Reserpine; Spiro Compounds; Stereotyped Behavior | 1974 |
The effect of amantadine on motor activity and catalepsy in rats.
Topics: Amantadine; Animals; Brain; Catalepsy; Catecholamines; Chlorpromazine; Cocaine; Desipramine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Methyltyrosines; Motor Activity; Nialamide; Rats; Rats, Inbred Strains; Reserpine; Spiro Compounds; Thiocarbamates | 1972 |
Acute toxic psychosis from suicidal overdosage of amantadine.
Topics: Acute Disease; Amantadine; Blood-Brain Barrier; Chlorpromazine; Humans; Male; Middle Aged; Parkinson Disease, Postencephalitic; Phenytoin; Psychoses, Substance-Induced; Suicide; Sympathetic Nervous System | 1971 |
[Study of the central action of amantadine].
Topics: Amantadine; Animals; Butyrophenones; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Electroencephalography; Epilepsy; Motor Activity; Rabbits; Rats; Reserpine | 1971 |
[Effect of the stimulators and inhibitors of the central dopaminergic structures on the kininogen level and kallikrein activity in the rat plasma].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Haloperidol; Kallikreins; Kininogens; Male; Rats; Receptors, Dopamine; Reserpine | 1980 |
Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C.
Topics: Amantadine; Aniline Compounds; Animals; Chlorphentermine; Chlorpromazine; Heptanes; Imipramine; Lipidoses; Liver; Lysosomes; Male; Pharmacology; Phospholipases; Phospholipases A; Propranolol; Rats; Tripelennamine; Type C Phospholipases | 1981 |
Clathrin- and caveolae-independent entry of feline infectious peritonitis virus in monocytes depends on dynamin.
Topics: Amantadine; Animals; beta-Cyclodextrins; Cats; Caveolae; Caveolin 1; Chlorpromazine; Clathrin; Coronavirus, Feline; Dynamins; Endocytosis; Genistein; In Vitro Techniques; Monocytes; Nystatin; rho GTP-Binding Proteins; Virus Internalization | 2008 |